EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)
Conditions: Acute Decompensated Heart Failure Interventions: Device: Reprieve Decongestion Management System; Drug: Diuretic (furosemide, bumetanide, torsemide, hydrochlorothiazide, and/or acetazolamide) Sponsors: Reprieve Cardiovascular, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
An Observational Study to Learn More About Vericiguat Treatment Patterns and Its Safety in People With Chronic Heart Failure With Reduced Ejection Fraction in Routine Medical Care in the United States
Conditions: Chronic Heart Failure With Reduced Ejection Fraction Interventions: Drug: Vericiguat (Verquvo, BAY1021189) Sponsors: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Gut Microbiome Profiling in Patients With Chronic Heart Failure
Conditions: Heart Failure With Reduced Ejection Fraction; Nonischemic Cardiomyopathy Sponsors: Stanford University; National Heart, Lung, and Blood Institute (NHLBI); American Heart Association Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF
Conditions: Heart Failure With Reduced Ejection Fraction Interventions: Device: Atrial pacing with respiratory sinus arrhythmia (RSA) variability; Device: Monotonic right atrial overdrive pacing Sponsors: Ceryx Medical Ltd; Cardiff and Vale University Health Board Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Impact of a Letter Encouraging Pneumococcal Vaccination on the 1-year Vaccination Rate in Heart Failure Patients With a Primary Care Physician
Conditions: Chronic Heart Failure Interventions: Other: Incentive letter for pneumococcal vaccination to the patient and to the GP Sponsors: University Hospital, Montpellier Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
Conditions: Chronic Heart Failure; CKD Stage 3 Interventions: Device: AquaPass System Sponsors: AquaPass Medical Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remodeling
Conditions: Heart Failure; Left Ventricular Dysfunction; Idiopathic Dilated Cardiomyopathy Interventions: Diagnostic Test: Thermodilution based assessment of coronary microcirculation Sponsors: Azienda Ospedaliera Universitaria Integrata Verona; Abbott Medical Devices Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Intracellular Magnesium and Heart Failure
Conditions: Heart Failure With Preserved Ejection Fraction; Hypomagnesemia Interventions: Other: Magnesium supplement Sponsors: University of Oxford; British Heart Foundation; Oxford University Hospitals NHS Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
TRAnscutaneous vaGUS Nerve Stimulation in Patients With Chronic Heart Failure
Conditions: Heart Failure; Heart Failure With Reduced Ejection Fraction; Heart Failure With Midrange Ejection Fraction Interventions: Device: Active tVNS; Device: Sham tVNS Sponsors: Fondazione Toscana Gabriele Monasterio; Azienda Ospedaliera Citt à della Salute e della Scienza di Torino Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines
Conditions: Type 2 Diabetes Mellitus; Obesity; Microvascular Disease; Macrovascular Disease; Major Adverse Cardiovascular Events; Nephropathy; Retinopathy; Heart Failure; All Cause Mortality Sponsors: Ali Aminian Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Short-term Mortality Prediction by the SOFA Score in Acute Decompensated Heart Failure
Conditions: Acute Decompensated Heart Failure Sponsors: Hanoi Heart Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Norepinephrine in the Management of General Anesthesia-Induced Arterial Hypotension in Chronic Heart Failure Patients
Conditions: Hypotension Interventions: Other: Cardiac output monitoring by the Starling ™ SV Sebac® Sponsors: University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2024 Category: Research Source Type: clinical trials
Telemedicine in Rural Patients With Heart Failure
Conditions: Heart Failure Interventions: Device: Movn app Sponsors: University of Texas Southwestern Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
The ROle of Compression StocKings in Heart Failure Patients
Conditions: Heart Failure ，Congestive; Leg Edema; Venous Insufficiency; Venous Ulcers Interventions: Device: low grade compression stockings (10-15 mmHg); Device: high grade compression stockings (20-30 mmHg) Sponsors: University of Maryland, Baltimore; National Institute on Aging (NIA) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
The Efficacy of Enavogliflozin in Heart Failure With Preserved Ejection Fraction
Conditions: Heart Failure, Preserved Ejection Fraction Interventions: Drug: SGLT2 inhibitor Sponsors: Samsung Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
